Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Current Assets (2023 - 2025)

Historic Current Assets for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $62.6 million.

  • Connect Biopharma Holdings' Current Assets changed N/A to $62.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.6 million, marking a year-over-year change of. This contributed to the annual value of $97.0 million for FY2024, which is 2088.24% down from last year.
  • Per Connect Biopharma Holdings' latest filing, its Current Assets stood at $62.6 million for Q3 2025.
  • In the past 5 years, Connect Biopharma Holdings' Current Assets registered a high of $138.2 million during Q2 2023, and its lowest value of $62.6 million during Q3 2025.
  • Its 3-year average for Current Assets is $100.2 million, with a median of $97.0 million in 2024.
  • Per our database at Business Quant, Connect Biopharma Holdings' Current Assets tumbled by 1612.11% in 2024 and then tumbled by 3291.0% in 2025.
  • Over the past 3 years, Connect Biopharma Holdings' Current Assets (Quarter) stood at $122.6 million in 2023, then decreased by 20.88% to $97.0 million in 2024, then tumbled by 35.44% to $62.6 million in 2025.
  • Its last three reported values are $62.6 million in Q3 2025, $77.8 million for Q2 2025, and $87.8 million during Q1 2025.